CN1660450A - Artificial comea having biological activital activity and preparing method - Google Patents

Artificial comea having biological activital activity and preparing method Download PDF

Info

Publication number
CN1660450A
CN1660450A CN 200410021915 CN200410021915A CN1660450A CN 1660450 A CN1660450 A CN 1660450A CN 200410021915 CN200410021915 CN 200410021915 CN 200410021915 A CN200410021915 A CN 200410021915A CN 1660450 A CN1660450 A CN 1660450A
Authority
CN
China
Prior art keywords
artificial cornea
porogen
solution
solvent
peripheral bracket
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200410021915
Other languages
Chinese (zh)
Other versions
CN1314461C (en
Inventor
李玉宝
许凤兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan University
Original Assignee
Sichuan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan University filed Critical Sichuan University
Priority to CNB2004100219157A priority Critical patent/CN1314461C/en
Publication of CN1660450A publication Critical patent/CN1660450A/en
Application granted granted Critical
Publication of CN1314461C publication Critical patent/CN1314461C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A bioactive artificial cornea is composed of optical center and peripheral scaffold. Its preparing process includes proportionally dissolving high-molecular polyvinyl alcohol is solvent, proportionally adding bioactive calcium salt, stirring, proportionally mixing it with pore-forming agent, moulding to obtain a hollow cylindrical scaffold, preparing optical center in the scaffold, and removing residual solvent, pore-forming agent and impurities in deionized water.

Description

Bioactive artificial cornea and preparation method thereof
Technical field:
The present invention relates to biomedical materials field, relate in particular to a kind of be used for corneal transplantation and alternate artificial cornea and preparation method thereof.
Background technology:
The artificial cornea substitutes biological cornea to save because of the blind clinical needs of keratopathy.Under situations such as repeatedly corneal transplantation failure, alkali burn, adacrya, severe corneal vascularization, the artificial cornea is the final only hope of saving and recovering vision.Existing artificial cornea mostly is the penetrating type artificial cornea, partly is made up of optical center and peripheral bracket.Optical center is to be made by light transmission good optical material, and it recovers the optical channel of eye; Peripheral bracket partly is provided by the key effect of stablizing the artificial cornea with the watertight junction and the support of host tissue that provides.The most complication of artificial cornea, as discharge, leakage of aqueous humor, formations of artificial cornea's caudacoria, endophthalmitis etc., all with artificial cornea's peripheral bracket partly and host's cornea tissue can not good bond and then can not play that effective support is fixed etc. and act on relevant.Artificial cornea's peripheral bracket portion be a kind of function, biological with engaging of host's cornea tissue, but not simple and mechanical joint.
Biological activity phosphate is very similar with the inorganic constituents in the natural sclerous tissues, has excellent biological compatibility, can inducing cell growth and division, soft tissues such as fiber blood vessel can be grown into, and have been widely used in orthopaedics and dentistry is clinical.But biological activity phosphate intensity is low, and fragility is big, is difficult for machine-shaping, and is difficult to bear the general external force of postoperative in the art.
It is simple to the purpose of this invention is to provide a kind of manufacturing process, and molding easily has excellent biological compatibility, bioactive artificial cornea that intensity is high and preparation method thereof.
The present invention is achieved in that
Bioactive artificial cornea of the present invention comprises optical center and peripheral bracket, and peripheral bracket is to be made by the material of following component and consumption: weight %
Biological activity calcium salt 0.1-20
High-molecular polyivnyl alcohol 1-15
Solvent 75-98
After high-molecular polyivnyl alcohol is dissolved in solvent, the adding porogen got mixture after adding biological activity calcium salt mix homogeneously got mixed solution, mixed solution: porogen=1: (0.5-2), weight ratio, it is the hollow circular cylinder peripheral bracket that mixture is placed mould molding, behind the shaping optical center it is removed residual solvent, porogen and other impurity in the peripheral bracket inner chamber in deionized water.
Mixture is inserted behind the mould at subzero 10-40 ℃ freeze forming.
The biological activity calcium salt is at least a in hydroxyapatite, nanometer hydroxyapatite, tricalcium phosphate, the tetracalcium phosphate, when inorganic matter when being multiple, is any weight ratio between the inorganic matter.
Solvent is the solution of water and dimethyl sulfoxide or glycerol, weight %<30 of water in solution, and what solvent also can be in dimethyl sulfoxide and the glycerol is at least a, when being two kinds, is any weight ratio.
The consumption of biological activity calcium salt is 10%, and the consumption of high-molecular polyivnyl alcohol is 10%, and the consumption of solvent is 80%, and fused solution: porogen=1: 1, porogen are sodium chloride.
Porogen is at least a in sodium chloride, potassium chloride, sodium bicarbonate, the sucrose, when being multiple, is any weight ratio.
The preparation method of the artificial cornea of the present invention comprises the steps:
1) preparation hollow cylinder shape peripheral bracket,
2) inner chamber that macromolecular solution is injected peripheral bracket carries out the crosslinked blank of making,
3) artificial cornea's blank of curing molding is cut into required size and makes semi-finished product,
4) semi-finished product are immersed in remove residual solvent in the deionized water, porogen and other impurity get finished product.
8, artificial cornea's according to claim 7 preparation method, it is characterized in that said macromolecular solution is that initiator, cross-linking agent, polymer monomer are mixed, be mixed with solution, or be poly-vinyl alcohol solution, polymer monomer is a kind of in methyl methacrylate, 2-hydroxyethyl methacry-late, the methacrylic acid.
The present invention has overcome existing artificial cornea's shortcoming, provides a kind of and ocular tissue to have good biocompatibility, and is functional and can produce artificial cornea of biological healing and preparation method thereof with cornea.Artificial cornea's support mostly is porous material and helps tissue and grow into, but existing many timbering materials biologically active not.High-molecular polyivnyl alcohol and bioactive P calcium salt composite porous material have the activity of phosphorus calcium salt, and its porous is through hole (as Fig. 1).Biological activity phosphate/polymer composite artificial cornea peripheral bracket material can improve shortcomings such as its material of biological activity phosphate roof pressure really up to the mark, blocked up, mechanical and difficult processing.This composite utilizes biological activity phosphate excellent biological compatibility and soft tissue to form the character of very strong chemical bonding on the interface, and raising artificial cornea holder part engages with host's cornea tissue.
Summary of the invention:
In order further to confirm to produce biological healing with cornea by the good biocompatibility of this artificial cornea, carried out zoopery.Slit lamp examination shows that the postoperative artificial cornea all is fixed in the flaggy capsule bag, does not see that material is discharged and infection etc.Art margo palpebrae redness, conjunctival congestion in the postoperative 3 days, shed tears, secretions is many, the basic disappearance in 1 week back, postoperative 6 days, the shallow-layer new vessels appears in limbus of corneae, how to be the burr shape to the growth of cornea central authorities from the superior rectus not-go-end, see that afterwards other all directions new vesselses grow into, postoperative 1 month, most new vesselses are invaded cornea central authorities, postoperative in the time of 3 months new vessels growth peak, 6 months cornea plant beds of postoperative central authorities retain the new vessels that attenuates in a large number, and multidigit is in deep layer substrate (Fig. 2,3).
Postoperative 1 month promptly has fibroblast, new vessels and a small amount of inflammatory cell to grow in the material hole of shirt rim, and forms with a small amount of collagen.The corneal stroma in shirt rim material and its front and back and the outside is pasted closely, seamless appearance.All holes are mainly collagenocyte and new vessels all by the cambium filling in 3 months marginal branch frame materials of postoperative.The nearly central optic of timbering material, visible collagen fiber cell in the hole.Corneal epithelium and in skin structure be kept perfectly (Fig. 4).Central optic cornea tissue poor adhesion, not seeing has epithelial cell or inflammatory cell to adhere to.
The zoopery interpretation of result shows that artificial cornea of the present invention has excellent biological compatibility, and the peripheral angles membrane tissue is grown in the hole of timbering material in a large number, complication such as do not see infection, dissolving, leakage of aqueous humor after the implantation or deviate from.Result of study shows that corneal epithelium and endothelium are kept perfectly, and show that this artificial cornea does not hinder the nutrition supply and the transportation of normal cornea.Artificial cornea's porous support of the present invention not only has the favorable tissue compatibility and good biological activity, can promote the embedding biological of new vessels and ocular tissue to connect with it, and can suppress growing into of unusual corneal epithelial cell and endotheliocyte, thereby reduced the generation of post-operative complication to a certain extent.Artificial cornea of the present invention helps improving artificial cornea's holder part and engages with the biological of host's cornea tissue; Help artificial cornea's retaining for a long time in vivo.Artificial cornea of the present invention helps improving the biological firm engagement of artificial cornea's holder part and host's cornea tissue, solves the engagement problems of optical center and peripheral bracket simultaneously, has the important clinical application prospect.
Description of drawings:
Fig. 1 is a peripheral bracket stereoscan photograph of the present invention
Fig. 2 implants between the rabbit corneal flaggy postoperative January for the artificial cornea, a large amount of new vesselses cornea central authorities of growing into.
Fig. 3 implants between the rabbit corneal flaggy postoperative March for the artificial cornea, and a large amount of newborn pipe ranges that are equipped with are gone into cornea central authorities, and as seen bracket edge does not have and expose.
Fig. 4 is for implanting back 3 months peripheral bracket tissue slice figure, and the timbering material hole is by collagenocyte, new vessels filling.
The specific embodiment:
Embodiment 1:
1, the 10g high-molecular polyivnyl alcohol is dissolved in the 80g dimethyl sulfoxide, add the 10g tricalcium phosphate and mix all back adding 100g sodium chloride granules, after stirring, mixture is poured in the column type mould, get peripheral bracket after the molding.
2, in the hollow circuit cylinder of peripheral bracket, inject methyl methacrylate, DIETHYLENE GLYCOL, azo two cyanogen mixed solution in different heptan, carry out crosslinked;
3, in type artificial cornea's blank is taken out the size that cuts into the artificial cornea;
4, goods are immersed in the deionized water, change deionized water at room temperature per 8 hours, take out after 72 hours.Porogen stripping in the composite forms loose structure at this moment, gets required artificial cornea.
Embodiment 2:
1, the 5g high-molecular polyivnyl alcohol is dissolved in the 80g glycerol, add the 200g potassium chloride particle behind the adding 15g tetracalcium phosphate mix homogeneously, after stirring, mixture is poured in the column type mould, get peripheral bracket after the molding.
2, injecting weight percent concentration in hollow circuit cylinder is 10% poly-vinyl alcohol solution, carries out crosslinked;
3, in type artificial cornea's blank is taken out the size that cuts into the artificial cornea;
4, goods are immersed in the deionized water, change deionized water at room temperature per 8 hours, take out after 72 hours.Porogen stripping in the composite forms loose structure at this moment, gets required artificial cornea.
Embodiment 3:
1, the 15g high-molecular polyivnyl alcohol is dissolved in 20g water and the 55g dimethyl sulfoxide, add 50g sucrose behind the adding 10g nanometer hydroxyapatite mix homogeneously, after stirring, pour mixture into the column type mould and make peripheral bracket.
2, in hollow circuit cylinder, inject 2-hydroxyethyl methacry-late, N,N methylene bis acrylamide, azo-bis-isobutyl cyanide mixed solution, carry out crosslinked;
3, in type artificial cornea's blank is taken out the size that cuts into the artificial cornea;
4, goods are immersed in the deionized water, change deionized water at room temperature per 8 hours, take out after 72 hours.Porogen stripping in the composite forms loose structure at this moment, gets required artificial cornea.
Embodiment 4:
1, the 1g high-molecular polyivnyl alcohol is dissolved in the solution of 68g dimethyl sulfoxide and 30g water, adds the hybrid particles of any mixing ratio of 1g hydroxyapatite, tricalcium phosphate, add 120g sodium bicarbonate behind the mix homogeneously, after stirring, mixture poured into make peripheral bracket in the mould.
2, in hollow circuit cylinder, inject methacrylic acid, N,N methylene bis acrylamide, dilauroyl peroxide mixed solution, carry out crosslinked;
3, in type artificial cornea's blank is taken out the size that cuts into the artificial cornea;
4, goods are immersed in the deionized water, change deionized water at room temperature per 8 hours, take out after 72 hours.Porogen stripping in the composite forms loose structure at this moment, gets required artificial cornea.
Embodiment 5:
The 13g high-molecular polyivnyl alcohol is dissolved in the 86.9g glycerol, pours mixture into mould after the even back adding of adding 0.1g phosphorio apatites mixed 80g sodium chloride stirs and make peripheral bracket.
It is identical with embodiment 1 in step.

Claims (8)

1, bioactive artificial cornea comprises optical center and peripheral bracket, it is characterized in that peripheral bracket is to be made by the material of following component and consumption: weight %
Biological activity calcium salt 0.1-20
High-molecular polyivnyl alcohol 1-15
Solvent 75-98
After high-molecular polyivnyl alcohol is dissolved in solvent, the adding porogen got mixture after adding biological activity calcium salt mix homogeneously got mixed solution, mixed solution: porogen=1: (0.5-2), weight ratio, it is the hollow circular cylinder peripheral bracket that mixture is placed mould molding, behind the shaping optical center it is removed residual solvent, porogen and other impurity in the peripheral bracket inner chamber in deionized water.
2, artificial cornea according to claim 1 is characterized in that mixture inserts behind the mould at subzero 10-40 ℃ freeze forming.
3, artificial cornea according to claim 1, it is characterized in that described biological activity calcium salt is at least a in hydroxyapatite, nanometer hydroxyapatite, tricalcium phosphate, the tetracalcium phosphate, when inorganic matter when being multiple, between the inorganic matter any weight ratio.
4, artificial cornea according to claim 1, it is characterized in that said solvent is the solution of water and dimethyl sulfoxide or glycerol, weight %<30 of water in solution, what solvent also can be in dimethyl sulfoxide and the glycerol is at least a, when being two kinds, be any weight ratio.
5, artificial cornea according to claim 1, the consumption that it is characterized in that the biological activity calcium salt is 10%, and the consumption of high-molecular polyivnyl alcohol is 10%, and the consumption of solvent is 80%, and fused solution: porogen=1: 1, porogen are sodium chloride.
6, artificial cornea according to claim 1 is characterized in that said porogen is at least a in sodium chloride, potassium chloride, sodium bicarbonate, the sucrose, when being multiple, is any weight ratio.
7, artificial cornea's according to claim 1 preparation method is characterized in that comprising the steps:
1) preparation hollow cylinder shape peripheral bracket,
2) inner chamber that macromolecular solution is injected peripheral bracket carries out the crosslinked blank of making,
3) artificial cornea's blank of curing molding is cut into required size and makes semi-finished product,
4) semi-finished product are immersed in remove residual solvent in the deionized water, porogen and other impurity get finished product.
8, artificial cornea's according to claim 7 preparation method, it is characterized in that said macromolecular solution is that initiator, cross-linking agent, polymer monomer are mixed, be mixed with solution, or be poly-vinyl alcohol solution, polymer monomer is a kind of in methyl methacrylate, 2-hydroxyethyl methacry-late, the methacrylic acid.
CNB2004100219157A 2004-02-27 2004-02-27 Artificial comea having biological activital activity and preparing method Expired - Fee Related CN1314461C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2004100219157A CN1314461C (en) 2004-02-27 2004-02-27 Artificial comea having biological activital activity and preparing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100219157A CN1314461C (en) 2004-02-27 2004-02-27 Artificial comea having biological activital activity and preparing method

Publications (2)

Publication Number Publication Date
CN1660450A true CN1660450A (en) 2005-08-31
CN1314461C CN1314461C (en) 2007-05-09

Family

ID=35010184

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100219157A Expired - Fee Related CN1314461C (en) 2004-02-27 2004-02-27 Artificial comea having biological activital activity and preparing method

Country Status (1)

Country Link
CN (1) CN1314461C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102580157A (en) * 2012-03-01 2012-07-18 深圳华明生物科技有限公司 Beta-tricalcium phosphate/polyvinyl alcohol composite hydrogel keratoprosthesis porous support material and preparation method thereof
CN102580147A (en) * 2012-02-28 2012-07-18 深圳华明生物科技有限公司 Keratoprosthesis and preparation method thereof
WO2013016907A1 (en) * 2011-08-01 2013-02-07 Yao Xiaoming Artificial cornea
CN103315701A (en) * 2013-05-16 2013-09-25 温州医学院附属第二医院 Aspheric testing bead
CN103830021A (en) * 2012-11-30 2014-06-04 复旦大学附属眼耳鼻喉科医院 Keratoprosthesis and manufacturing method thereof
CN106473837A (en) * 2016-03-17 2017-03-08 黄飞 Artificial cornea

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101658445B (en) * 2008-08-29 2011-08-17 四川大学 Integrated artificial cornea and preparing method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108428A (en) * 1988-03-02 1992-04-28 Minnesota Mining And Manufacturing Company Corneal implants and manufacture and use thereof
CN1120023C (en) * 1998-04-29 2003-09-03 王滨生 Centrifugal method for preparing cornea collagen film
CN1141067C (en) * 2001-06-29 2004-03-10 清华大学 Process for preparing artificial cornea by filtering out expanded polymer particles

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013016907A1 (en) * 2011-08-01 2013-02-07 Yao Xiaoming Artificial cornea
CN102580147A (en) * 2012-02-28 2012-07-18 深圳华明生物科技有限公司 Keratoprosthesis and preparation method thereof
CN102580147B (en) * 2012-02-28 2014-10-01 深圳华明生物科技有限公司 Keratoprosthesis and preparation method thereof
CN102580157A (en) * 2012-03-01 2012-07-18 深圳华明生物科技有限公司 Beta-tricalcium phosphate/polyvinyl alcohol composite hydrogel keratoprosthesis porous support material and preparation method thereof
CN103830021A (en) * 2012-11-30 2014-06-04 复旦大学附属眼耳鼻喉科医院 Keratoprosthesis and manufacturing method thereof
CN103830021B (en) * 2012-11-30 2016-08-10 复旦大学附属眼耳鼻喉科医院 A kind of artificial cornea and preparation method thereof
CN103315701A (en) * 2013-05-16 2013-09-25 温州医学院附属第二医院 Aspheric testing bead
CN106473837A (en) * 2016-03-17 2017-03-08 黄飞 Artificial cornea

Also Published As

Publication number Publication date
CN1314461C (en) 2007-05-09

Similar Documents

Publication Publication Date Title
EP0862391B1 (en) Retrievable bioartificial implants
US7807150B2 (en) Injectable composition containing crosslinkable material and cells for forming animal tissue
DE69917339T2 (en) POROUS POLYMER SUPPORT FABRICS FOR TISSUE TECHNOLOGY
DE69433843T2 (en) Biodegradable implant precursor
ES2197700T3 (en) POROUS COMPOSITE MATRIX, ITS PRODUCTION AND USE.
US20210079170A1 (en) Preparation method of 4d chitosan-based thermosensitive hydrogel
CN101658445B (en) Integrated artificial cornea and preparing method thereof
CN106750573A (en) A kind of shitosan alginate porous gel and its methods for making and using same
CN1314461C (en) Artificial comea having biological activital activity and preparing method
EP1015042A1 (en) Improved hydrogel for tissue engineering
ES2538696T3 (en) Cell sheets for the formation of the ectocornea, method to produce them and method to use them
CN113926001B (en) Bionic cornea and preparation method thereof
CN101066471A (en) Cell-eliminating coanea matrix and its prepn process
Fenglan et al. Preparation and in vivo investigation of artificial cornea made of nano-hydroxyapatite/poly (vinyl alcohol) hydrogel composite
JP4002299B2 (en) Improved hydrogel for tissue treatment
KR100737167B1 (en) Method for preparing of a porous osteochondral composite scaffold
Bao et al. Agar/collagen membrane as skin dressing for wounds
JP2004501700A (en) Biocompatible polymer having three-dimensional structure using communicating cells, method for preparing the same, and application in medicine and surgery
CN112107730A (en) Degradable biological hybrid high-strength hydrogel scaffold and preparation method and application thereof
CN1051918A (en) The preparation method of biocompatible polymer material
US20240123120A1 (en) High-adhesion artificial corneal endothelial sheet, preparation method and use thereof
US20120108689A1 (en) Process for forming a porous pva scaffold using a pore-forming agent
FR2630638A1 (en) OCULAR IMPLANT AND METHOD FOR PREPARING THE SAME
Dupont et al. Biocompatibility of human collagen type IV intracorneal implants
CN114129889A (en) Annular microneedle for ophthalmology

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070509